465.0251 Generic drugs; removal from formulary under specified circumstances.—
(1) The Board of Pharmacy and the Board of Medicine shall remove any generic named drug product from the formulary established by s. 465.025(6), if every commercially marketed equivalent of that drug product is “A” rated as therapeutically equivalent to a reference listed drug or is a reference listed drug as referred to in “Approved Drug Products with Therapeutic Equivalence Evaluations” (Orange Book) published by the United States Food and Drug Administration.
(2) Nothing in this act shall alter or amend s. 465.025 as to existing law providing for the authority of physicians to prohibit generic drug substitution by writing “medically necessary” on the prescription.
History.—ss. 1, 2, ch. 2001-146.
Section: Previous 465.0197 465.022 465.023 465.0235 465.024 465.0244 465.025 465.0251 465.0252 465.0255 465.026 465.0265 465.0266 465.027 465.0275 NextLast modified: September 23, 2016